Form 4: Kenvue Director Richard E. Allison Jr. Reports Share Units
Insider Transaction Filing
Richard E. Allison Jr., a Director at Kenvue Inc., reported the acquisition of 1,413 Deferred Share Units (DSUs) on June 29, 2026, as part of a deferred compensation plan.
Summary
- Richard E. Allison Jr., a Director at Kenvue Inc. (KVUE), has filed a Form 4 statement detailing a transaction on June 29, 2026.
- The transaction involved the acquisition of 1,413 Deferred Share Units (DSUs).
- These DSUs represent the right to receive one share of Kenvue's common stock upon the reporting person's separation from service.
- The DSUs were acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
- The reported amount of 1,413 DSUs includes those acquired as dividend equivalents.
- Following this transaction, the reporting person beneficially owns 49,797.67 DSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation-related transaction for a director and does not provide new financial performance data or strategic insights.
Positives
- Director Allison's continued participation in the deferred compensation plan indicates ongoing commitment to the company.
- The acquisition of DSUs, which are settled in shares, aligns the director's interests with those of common stockholders.
- The inclusion of dividend equivalents suggests a mechanism for DSUs to grow in value over time, mirroring shareholder returns.
Negatives
- The filing does not disclose any negative financial or operational information.
- No disposal of securities or negative financial implications are noted in this transaction.
Risks
- The value of the DSUs is subject to the future performance and stock price of Kenvue Inc.
- The settlement of DSUs is contingent upon the reporting person's separation from service, introducing a timing element to the realization of value.
Future Outlook
The filing does not contain forward-looking statements or guidance. The DSUs are to be settled in shares of common stock following the reporting person's separation from service.
Industry Context
StockSavvy.ai notes that the use of Deferred Share Units (DSUs) is a common practice in the pharmaceutical and consumer health sectors for executive and director compensation, aiming to retain talent and align long-term interests with shareholders.
Stakeholder Impact
- Shareholders: The transaction reinforces the alignment of director compensation with the company's stock performance.
- Employees: This is a standard compensation practice for directors and does not directly impact most employees.
- Management: The filing is a routine disclosure for a director and does not indicate any changes in management strategy.
Next Steps
- Settlement of Deferred Share Units in shares of common stock upon reporting person's separation from service.
Key Dates
| Date | Description |
|---|---|
| 06/29/2026 | Transaction Date for acquisition of Deferred Share Units. |
| 07/01/2026 | Date of Report Signature. |
Keywords
Kenvue Inc., KVUE, Form 4, SEC Filing, Director, Deferred Share Units, DSU, Deferred Compensation, Insider Transaction, Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.